David E. Galey, Ph.D. - Publications

Affiliations: 
2005 University of Kentucky, Lexington, KY 
Area:
Immunology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Steiner JP, Galey D, Haughey NJ, Asch D, Nath A. Neuroprotective and antiretroviral effects of the immunophilin ligand GPI 1046. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 49-57. PMID 18040826 DOI: 10.1007/S11481-006-9060-0  0.51
2006 Caporello E, Nath A, Slevin J, Galey D, Hamilton G, Williams L, Steiner JP, Haughey NJ. The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load. Journal of Neurochemistry. 98: 146-55. PMID 16805804 DOI: 10.1111/J.1471-4159.2006.03863.X  0.506
2006 Patel J, Galey D, Jones J, Ray P, Woodward JG, Nath A, Mumper RJ. HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant. Vaccine. 24: 3564-73. PMID 16516358 DOI: 10.1016/J.Vaccine.2006.01.065  0.418
2005 Hollman AM, Christian DA, Ray PD, Galey D, Turchan J, Nath A, Bhattacharyya D. Selective isolation and purification of tat protein via affinity membrane separation. Biotechnology Progress. 21: 451-9. PMID 15801785 DOI: 10.1021/Bp049804Z  0.419
2004 Conant K, St Hillaire C, Anderson C, Galey D, Wang J, Nath A. Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. Journal of Neurovirology. 10: 21-8. PMID 14982725 DOI: 10.1080/13550280490261699  0.422
Show low-probability matches.